广州凌玮科技股份有限公司 关于召开2023年度第三次临时股东大会的通知 本公司及董事会全体成员保证信息披露内容的真实、准确和完整，没有虚假 记载、误导性陈述或重大遗漏。 一、召开会议的基本情况 1、股东大会届次：2023 年度第三次临时股东大会 2、召集人：公司董事会 3、会议召开的合法、合规性：本次股东大会的召开符合有关法律、行政法 规、部门规章、规范性文件和公司章程的有关规定。 证券代码：301373 证券简称：凌玮科技 公告编号：2023-54 4、会议召开的日期和时间 （1）现场会议时间：2023 年 9 月 11 日（星期一）15:00（参加现场会议的 股东请于会前 20 分钟到达开会地点，办理登记手续）。 （2）网络投票时间：通过深圳证券交易所交易系统进行网络投票的时间为 2023 年 9 月 11 日的交易时间，即 9:15-9:25，9:30-11:30 和 13:00-15:00；通过深 圳证券交易所互联网投票系统进行网络投票的时间为 2023 年 9 月 11 日 9:15- 15:00。 5、会议召开方式：本次股东大会采取现场投票与网络投票相结合的方式。 公司将通过深圳证券交易所交易系统 ...

广州凌玮科技股份有限公司独立董事 1、经核查，公司 2023 年上半年不存在控股股东及其他关联方违规占用公 司资金的情况，也不存在以前年度发生并累积至 2023 年 6 月 30 日的控股股东 及其他关联方非经营性占用公司资金的情况，公司与其他关联方之间发生的资 金往来均为正常经营性往来。 2、经核查，公司及子公司 2023 年上半年未开展对外担保业务，也不存在 其他以前年度发生并累计至 2023 年 6 月 30 日的对外担保情形。 3、公司严格遵守《公司法》《公司章程》及其它有关法律法规的规定，严 格控制相关风险，不存在控股股东及其他关联方违规占用公司资金及公司违规 担保情况，不存在损害公司及股东利益的情形。 二、关于公司 2023 年半年度募集资金存放与使用情况的独立意见 《2023 年半年度募集资金存放与使用情况的专项报告》的编制符合相关法 律、法规的规定，真实、客观反映了公司 2023 年 1-6 月募集资金的存放与使用 关于公司第三届董事会第十五次会议事项的独立意见 广州凌玮科技股份有限公司（以下简称"公司"）于 2023 年 8 月 23 日召开 了第三届董事会第十五次会议，作为公司的独立董事， ...

证券代码：301373 证券简称：凌玮科技 公告编号：2023-48 广州凌玮科技股份有限公司 一、监事会会议召开情况 广州凌玮科技股份有限公司（以下简称"公司"）第三届监事会第十三次会议 通知于 2023 年 8 月 14 日以信息通知等方式发出，并于 2023 年 8 月 23 日在公司 总部大会议室以现场结合通讯方式召开。本次会议由监事会主席陈鹏辉先生召集 和主持，应到监事 3 人，实到监事 3 人，公司董事会秘书、证券事务代表列席本 次会议。本次会议的召集和召开符合《公司法》等有关法律、行政法规、部门规 章、规范性文件和《公司章程》的有关规定。 二、监事会会议审议情况 第三届监事会第十三次会议决议公告 本公司及监事会全体成员保证信息披露内容的真实、准确和完整，没有虚假 记载、误导性陈述或重大遗漏。 经与会监事充分合议并表决，形成如下决议： （一）会议以 3 票同意、0 票反对、0 票弃权的表决结果，审议通过了《2023 年半年度报告及其摘要》。 经核查，监事会认为：公司 2023 年半年度报告及其摘要的编制和审核程序 符合法律、行政法规及中国证监会的规定，报告内容真实、准确、完整地反映了 公司的实际情 ...

证券代码：301373 证券简称：凌玮科技 公告编号：2023-50 广州凌玮科技股份有限公司 2023 年半年度募集资金存放与使用情况的专项报告 本公司及董事会全体成员保证信息披露内容的真实、准确和完整，没有虚假 记载、误导性陈述或重大遗漏。 根据《上市公司监管指引第2号—上市公司募集资金管理和使用的监管要求》 《深圳证券交易所上市公司自律监管指引第2号—创业板上市公司规范运作》等 相关规定，广州凌玮科技股份有限公司（以下简称"公司"）董事会编制了《2023 年半年度募集资金存放与使用情况的专项报告》，相关内容如下： 一、募集资金基本情况 （一）实际募集资金金额及到账时间 经中国证券监督管理委员会《关于同意广州凌玮科技股份有限公司首次公开 发行股票的批复》（证监许可〔2022〕2253 号）批准，公司首次公开发行人民币 普通股（A 股）2,712.00 万股，发行价格为 33.73 元/股，募集资金总额 914,757,600.00 元，扣除不含税的发行费用 94,030,758.27 元后，实际募集资金净 额为 820,726,841.73 元。 上述募集资金已于 2023 年 1 月 31 日划至公司指 ...

证券代码：301373 证券简称：凌玮科技 公告编号：2023-46 广州凌玮科技股份有限公司 关于终止代理 BYK 产品的进展公告 本公司及董事会全体成员保证信息披露内容的真实、准确和完整，没有虚假 记载、误导性陈述或重大遗漏。 一、概述 广州凌玮科技股份有限公司（以下简称 "公司"）于 2023 年 6 月 29 日召开 第三届董事会第十三次会议，审议通过了《关于下属子公司终止代理 BYK 产品 的议案》，基于聚焦发展纳米新材料主业，并考虑代理业务的收入、利润下降风 险及毛利率水平等因素，同意全资子公司成都展联商贸有限公司（以下简称"成 都展联"）终止与 BYK-Chemie GmbH（中文名称"毕克化学有限公司"，以下简 称"BYK 公司"）的代理合作，并授权公司管理层与 BYK 公司商讨《产品销售 协议》终止事项以及签署相关协议事项。详见公司指定信息披露媒体巨潮资讯网 （http://www.cninfo.com.cn）上的相关公告。 二、终止代理的进展情况 近日，成都展联与 BYK 公司经过友好协商，共同签订了《终止与和解协议》。 根据协议约定，双方之间的代理合作关系将于 2023 年 8 月 15 ...

广州凌玮科技股份有限公司 关于公司收购股权的进展公告 证券代码：301373 证券简称：凌玮科技 公告编号：2023-45 广州凌玮科技股份有限公司董事会 2023 年 8 月 10 日 1 本公司及董事会全体成员保证信息披露内容的真实、准确和完整，没有虚假 记载、误导性陈述或重大遗漏。 广州凌玮科技股份有限公司（以下简称 "公司"）于 2023 年 7 月 14 日召开 第三届董事会第十四次会议及第三届监事会第十二次会议，审议通过《关于公司 收购湖南聚涂新材料有限公司 100%股权暨关联交易的议案》，同意公司以自有 资金 649.53 万元向聚涂科技（东莞）有限公司收购其持有湖南聚涂新材料有限 公司 100%的股权，具体内容详见公司在巨潮资讯网上披露的相关公告。现将有 关进展情况公告如下： 截至本公告披露之日，公司已按照协议约定向交易对手方支付了本次收购的 全额款项，且目标公司湖南聚涂新材料有限公司已办理完成股东变更的工商登记 手续并取得换发的《营业执照》。本次交易已完成股权交割，湖南聚涂新材料有 限公司将纳入公司合并报表范围。 备查文件：湖南聚涂新材料有限公司出具的《登记通知书》和《营业执照》。 特此公告 ...

Financial Performance - The company's revenue for Q1 2023 was CNY 99,118,247.53, representing a 12.01% increase compared to CNY 88,494,032.16 in the same period last year[5] - Net profit attributable to shareholders was CNY 25,027,962.05, up 29.11% from CNY 19,384,252.78 year-over-year[5] - The company reported a basic earnings per share of CNY 0.28, a 16.67% increase from CNY 0.24 in the same period last year[5] - The net profit attributable to the parent company for Q1 2023 was CNY 25,027,962.05, an increase from CNY 19,384,252.78 in Q1 2022, representing a growth of approximately 29.4%[27] - The basic and diluted earnings per share for Q1 2023 were both CNY 0.28, up from CNY 0.24 in the same period last year, indicating a 16.7% increase[27] Cash Flow and Liquidity - The net cash flow from operating activities decreased significantly by 96.46%, amounting to CNY 483,162.66 compared to CNY 13,647,519.91 in the previous year[5] - Cash inflows from operating activities totaled CNY 89,342,312.12, compared to CNY 85,569,761.55 in the previous year, reflecting a growth of about 3.3%[29] - The total cash outflow from operating activities was CNY 88,859,149.46, which increased from CNY 71,922,241.64 in Q1 2022, marking a rise of approximately 23.5%[29] - The net cash flow from investing activities was -CNY 504,374,703.01, worsening from -CNY 218,866,790.19 in the same quarter last year[30] - The net cash flow from financing activities was CNY 822,300,040.40, a significant improvement from -CNY 493,364.14 in Q1 2022[30] - The ending cash and cash equivalents balance for Q1 2023 was CNY 572,246,065.39, a substantial increase from CNY 75,861,303.57 at the end of Q1 2022[30] - The company reported a total cash increase of CNY 318,224,911.25 in Q1 2023, contrasting with a decrease of CNY 205,738,173.90 in the same period last year[30] Assets and Liabilities - Total assets increased by 114.95% to CNY 1,550,439,215.35 from CNY 721,291,394.71 at the end of the previous year[5] - The company reported a total liability of RMB 86.89 million, down from RMB 103.54 million at the beginning of the year, indicating a reduction in debt[23] - The company's equity attributable to shareholders increased to RMB 1.46 billion from RMB 617.23 million at the beginning of the year, reflecting strong financial performance[23] Shareholder Information - The total number of common shareholders at the end of the reporting period is 21,794[12] - The largest shareholder, Hu Yingni, holds 46.79% of the shares, totaling 50,755,565 shares[12] - The second-largest shareholder, Xinyu Gaoling Investment Partnership, holds 6.45% with 7,000,000 shares[12] - The company has a significant concentration of ownership, with the top 10 shareholders holding a combined 69.63% of the shares[12] - The company has a total of 81,352,091 restricted shares at the beginning of the period, with 1,901,719 shares added during the period, resulting in a total of 83,253,810 restricted shares at the end[15] - Hu Yingni's shares are subject to a lock-up period until February 8, 2026[15] Operational Highlights - The company raised CNY 822,300,040.40 from financing activities, a significant increase of 166,772.03% compared to the previous year[10] - The company received government subsidies amounting to CNY 3,438,242.49, which contributed to its non-operating income[6] - The company’s capital reserve increased by 641.07% to CNY 917,401,040.87 due to the issuance of new shares[9] - The company’s management expenses rose by 95.06% to CNY 5,439,001.06, attributed to increased costs related to annual meetings and management personnel[9] Strategic Initiatives - The company is exploring market expansion strategies, although specific details were not disclosed in the provided content[13] - The company is focused on new product development and technological advancements, but specific figures or timelines were not mentioned[13] - The company has established employee stock ownership platforms to align interests between management and employees[13] - The company has a strategic plan for future growth, including potential mergers and acquisitions, although no specific targets were identified[13] - The company raised a net amount of RMB 820 million from its initial public offering, with an oversubscription of approximately RMB 340 million, which will enhance production capacity and R&D capabilities[17] - The company plans to invest RMB 1 billion in a Phase II project in Ma'anshan, which includes the construction of a catalyst carrier and water-based resin production facility, as well as a research and development center[18] Research and Development - Research and development expenses for the quarter were RMB 4.07 million, compared to RMB 3.69 million in the previous year, highlighting a focus on innovation[26]

Sales Performance - The company's overseas sales revenue accounted for 17.80% of total revenue in 2022, up from 7.15% in 2021, representing a growth of 10.65% [2] Market Potential - The silica industry in China is experiencing stable growth, with increasing downstream demand and a broad market capacity for future development [3] - The company has significant growth potential compared to foreign giants, with room for expansion in product variety and overall sales scale [3] - There is a pressing need for domestic high-performance materials due to insufficient domestic production capacity and reliance on imports, particularly in the high-end silica market [3] Technology and Product Development - The company is focusing on high-value-added products, including nanometer silica, which is widely used in various industries such as coatings, plastics, and electronics [4] - The company has patented technologies for catalysts and drug carriers, and is actively exploring higher technology applications for silica [4] - The gel method for silica production results in smaller particle sizes and higher stability compared to the precipitation method, although it is less suitable for large-scale production [3] Production Capacity and Utilization - The production capacity utilization rates for nanometer silica and alumina were 129.47% and 124.79% respectively in 2022 [6] - The company is actively promoting the construction of projects to expand production capacity, including a project for an annual output of 20,000 tons of ultra-fine silica aerogel [6] Investor Relations and Market Confidence - The company emphasizes compliance with information disclosure regulations and has no undisclosed significant information [6] - The management is committed to enhancing operational management, product innovation, and market expansion to improve overall competitiveness and profitability [8] - The company acknowledges the impact of market fluctuations on stock prices and is focused on long-term, sustainable growth [8]

Market Potential - The domestic nano-silica market has significant growth potential, driven by stable demand and economic recovery [2][3] - China is a major consumer of silica, with consumption maintaining steady growth in recent years [2][3] Company Growth and Competitive Advantage - The company has substantial growth opportunities compared to foreign giants, with room for expansion in product variety and sales scale [3][4] - There is a strong demand for domestic high-performance silica products due to insufficient local production and reliance on imports [3][4] - The company focuses on high-end nano-silica, positioning itself for domestic substitution amid ongoing trade tensions and stricter environmental policies [3][4] Order and Revenue Insights - In Q1 2023, the company observed a stable recovery in downstream orders, particularly in traditional products like light stabilizers and adsorbents [3][4] - New products such as anti-rust pigments and opening agents are in the early stages of market expansion, with significant import substitution potential [3][4] - The company’s revenue from nano-materials reached CNY 343.78 million in 2022, a 12.62% increase year-on-year, compensating for declines in other product lines [5][6] Financial Performance - The company’s total revenue in 2022 saw a slight decline of 1.94%, primarily due to challenges in the international market affecting agent products [5][6] - Net profit for 2022 was CNY 90.99 million, reflecting a 34.71% increase, driven by the high gross margin of nano-materials [5][6] R&D and Market Strategy - The company emphasizes R&D, aiming to enhance its technological capabilities and develop high-value products [6][7] - A stable management team with extensive experience supports the company’s long-term development [6][7] Supply Chain and Cost Management - The company’s procurement of sodium silicate and concentrated sulfuric acid accounted for approximately 18.21% of total purchases in 2022 [7] - The company has stable supplier relationships, ensuring timely and sufficient raw material supply [7] International Market Expansion - In 2022, overseas sales revenue reached CNY 71.41 million, a 143.92% increase, indicating strong potential for international market growth [7]

Production Capacity and Investment - The company is constructing a new production facility with an annual capacity of 20,000 tons of ultra-fine silica aerogel, expected to be operational by Q4 2023 [2] - New production capacity will be flexibly allocated based on market demand for various products, including dispersants, adsorbents, opening agents, and anti-rust pigments [3] Product Development and Market Position - The company focuses on high-end applications of nano-silica, establishing a strong technical barrier that requires significant investment and years of technical accumulation for competitors to enter the market [3] - The company is the only domestic manufacturer of silica-based opening agents, currently in the early stages of market promotion and import substitution [4][5] Market Trends and Demand Recovery - The company observed a stable recovery in traditional products like dispersants and adsorbents, while anti-rust pigments and opening agents are in the early stages of market expansion [4] - In Q1 2023, the company noted a positive outlook for market recovery based on order volume [3] Financial Performance and Shareholder Returns - In 2022, the company distributed cash dividends of RMB 3.00 per 10 shares, with a total share capital of 108,472,091 shares [5] - The company achieved overseas revenue of RMB 71.41 million in 2022, a 143.92% increase compared to the previous year, with clients in over 50 countries [5] Future Projects and Strategic Focus - The company plans to build a second phase project in Ma'anshan focused on catalyst carriers, recognizing the significant market potential and current reliance on imported products [6]